SCHEMBL18436706

SCHEMBL18436706

Cc1c(-c2ccc(N3CC(C)O[C@H](C)C3)cc2)cnc2c(-c3ccc(C#N)cc3)cccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.42
KDM1A O60341 4/20 0.39
LRRK2 Q5S007 3/20 0.39
HRH3 Q9Y5N1 3/20 0.38
PRKDC P78527 1/20 0.38
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MTOR P42345 1/20 0.36
SMO Q99835 2/20 0.35
PGR P06401 1/20 0.35
GPR183 P32249 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
HIF1A Q16665 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17127848 1.00 HRH4 (0.42) HRH4KDM1ALRRK2HRH3PRKDC
SCHEMBL21336664 1.00 HRH4 (0.42) HRH4KDM1ALRRK2HRH3PRKDC
SCHEMBL18436076 0.90 HRH4 (0.42) HRH4KDM1ALRRK2HRH3PRKDC
SCHEMBL18436075 0.90 HRH4 (0.42) HRH4KDM1ALRRK2HRH3PRKDC
SCHEMBL17127887 0.90 HRH4 (0.42) HRH4KDM1ALRRK2HRH3PRKDC
SCHEMBL17127921 0.89 SMO (0.44) HRH4KDM1ALRRK2ALDH1A1KDM4E
SCHEMBL18436199 0.89 SMO (0.44) HRH4KDM1ALRRK2ALDH1A1KDM4E
SCHEMBL17128085 0.89 HRH4 (0.41) HRH4KDM1ALRRK2HRH3PRKDC
SCHEMBL17127854 0.89 HRH4 (0.41) HRH4KDM1ALRRK2HRH3PRKDC
SCHEMBL18436812 0.89 HRH4 (0.41) HRH4KDM1ALRRK2HRH3PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3124482-A1 QUINOLINE DERIVATIVES AS SMO INHIBITORS GUANGDONG ZHONGSHENG PHARMACEUTICAL CO., LTD (CN) 2017-02-01 EP disclosed